Press Releases
Published: January 09, 2019

Propeller Health announces My Pharmacy, enabling in-app pharmacy experience for patients with asthma and COPD

Walgreens is the first to be included in the new My Pharmacy feature

MADISON, Wis., Jan. 9, 2019 /PRNewswire/ — Propeller Health, a leading digital therapeutics company, today announced My Pharmacy, connecting Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services in the Propeller mobile app.

Walgreens is the first pharmacy to be included in the new My Pharmacy feature, giving Walgreens patients a single platform for managing their asthma or COPD medication regimen.

propeller
Through My Pharmacy, patients will be able to refill prescriptions for in-store pickup at Walgreens pharmacies, locate a nearby Walgreens pharmacy, talk live with a pharmacist through Walgreens Pharmacy Chat and check their Walgreens Balance Rewards™ points.

Through My Pharmacy, patients will be able to refill prescriptions for in-store pickup at Walgreens pharmacies, locate a nearby Walgreens pharmacy, talk live with a pharmacist through Walgreens Pharmacy Chat and check their Walgreens Balance Rewards™ points, all within the Propeller app.

“The ability to refill a prescription or talk to a pharmacist through an existing digital health tool is an important step in making care easier, faster and less stressful for patients,” said Greg Tracy, chief technology officer for Propeller Health. “We’re thrilled to work with Walgreens on this launch and hope our collaboration will serve as a blueprint for future pharmacy integrations within our platform.”

My Pharmacy will be rolled out to users on Propeller for iOS this week and will be available on Propeller for Android in the coming month, with plans to expand to other programs and partners this year.

“Our collaboration with Propeller is the latest example of our focus on working with healthcare companies to bring new, innovative services to our patients and customers,” said Giovanni Monti, VP and director of healthcare innovation, Walgreens Boots Alliance.

About Propeller Health
Propeller Health is a leading digital therapeutics company dedicated to the development and commercialization of measurably better medicines. Propeller creates products to more effectively treat chronic respiratory disease and improve clinical outcomes for patients through connectivity, analytics, and companion digital experiences. The Propeller platform is used by patients, physicians and healthcare organizations in the United States, Europe and Asia. For more information, visit www.propellerhealth.com.

You Might Also Like

Propeller Health Named a Winner of Fierce Healthcare Innovation Awards 2022

Propeller Health’s precision digital health platform wins the Clinical Information Management category of the Fierce Healthcare Innovation Awards 2022. The platform enables physicians and care teams to proactively identify at-risk patients in between routine visits and provide more timely clinical interventions.

MADISON, WI, November 15, 2022 – Propeller Health, a leader in precision digital health, today announces its platform for chronic condition management is a Fierce Healthcare Innovation Awards 2022 winner. The program showcases outstanding innovation that is driving improvements and transforming the industry. The Propeller Digital Health Platform for Chronic Condition Management (The Propeller Platform”) enables proactive clinical care by collecting objective patient data and displaying resulting insights directly within a provider’s native workflow. 

At Propeller, data itself is only the beginning – activating it is what powers patient care,” said Susa Monacelli, Propeller Health General Manager. By surfacing the data within clinicians' existing workflow through EHR integrations, we enable their treatment decisions and help identify at-risk patients. Patient self-management coupled with proactive clinician intervention helps improve clinical outcomes and, in turn, economic value for health systems, payers, and patients. Our focus is to do this across connected medications and therapies to change healthcare at scale.”

Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems

Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.

MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary disease (COPD), today announced three exciting updates and new solutions to bring its clinically proven, FDA-cleared platform to more patients, providers and health systems.

Integrations expand the reach of Propeller’s digital platform to more health systems
Propeller Health research shows digital health programs help improve outcomes for vulnerable and underserved populations with chronic respiratory conditions
News Announcement at HLTH 2021, Boston MA, October 18, 2021 MADISON, Wisconsin, October 18, 2021 - Propeller Health, a leader in digital health and therapeutics for asthma and chronic obstructive pulmonary disease (COPD), revealed two recent studies that showed that digital health interventions alongside appropriate care resources and tools can expand access and improve outcomes for elderly and underserved populations. Propeller’s digital health platform includes Bluetooth® connected inhaler sensors that chime medication reminders and record inhaler medication use, paired with a smartphone app that provides education and feedback to support self-management. In a study1 conducted in partnership with Desert Oasis Healthcare, Propeller evaluated the effect of digital health intervention on healthcare resource utilization and medication use in patients with COPD. 56 patients with COPD, average age 75, were enrolled by their clinical pharmacists, who received alerts through Propeller’s clinician portal whenever patients showed low controller medication adherence or high rescue inhaler use.